Kyle Rodda, Financial Market Analyst at Capital.com, provides an overview of the "GRANOLAS" stocks in Europe (which comprises GSK, Roche, ASML, Nestle, Novartis, Novo Nordisk, L’Oreal, LVMH, AstraZeneca, SAP and Sanofi) and their common traits; whether they have performed in the past year against the backdrop of a sluggish European economy; and how they stack up against the "Magnificent 7" group of stocks.
Presented by Ryan Huang
Podcast edited by Emaad Akhtar (eakhtar@sph.com.sg)